18.37
18.37 (0%)
As of Apr 23, 2025
Innoviva, Inc. [INVA]
Source:
Company Overview
Innoviva, Inc. is a company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (“IST”), and a portfolio of strategic investments in other healthcare assets.
Country | United States |
Headquarters | burlingame, california |
Phone Number | 6502389600 |
Industry | manufacturing |
CEO | Pavel Raifeld |
Website | www.inva.com |